No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs17091371 |
chr8:19625038-19625039 |
Weak transcription Enhancers Flanking Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
2 |
rs73667412 |
chr8:19625044-19625045 |
Weak transcription Enhancers Flanking Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
3 |
rs575295342 |
chr8:19625069-19625070 |
Weak transcription Enhancers Flanking Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs535846168 |
chr8:19625203-19625204 |
Weak transcription Enhancers Flanking Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs7819691 |
chr8:19625232-19625233 |
Weak transcription Enhancers Flanking Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
6 |
rs575808187 |
chr8:19625244-19625245 |
Weak transcription Enhancers Flanking Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs141580381 |
chr8:19625299-19625300 |
Weak transcription Enhancers Flanking Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs189111814 |
chr8:19625331-19625332 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs557481817 |
chr8:19625339-19625340 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs578173433 |
chr8:19625377-19625378 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs540708523 |
chr8:19625394-19625395 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs560543396 |
chr8:19625399-19625400 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs149987112 |
chr8:19625411-19625412 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs549065574 |
chr8:19625448-19625449 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs13282247 |
chr8:19625464-19625465 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
16 |
rs1492637 |
chr8:19625510-19625511 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
17 |
rs555601121 |
chr8:19625512-19625513 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs551590249 |
chr8:19625616-19625617 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs13280698 |
chr8:19625619-19625620 |
Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
20 |
rs191167291 |
chr8:19625653-19625654 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs547114570 |
chr8:19625683-19625684 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs374858284 |
chr8:19625702-19625703 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs117258836 |
chr8:19625748-19625749 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs13248141 |
chr8:19625762-19625763 |
Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
25 |
rs541420279 |
chr8:19625766-19625767 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs555841111 |
chr8:19625771-19625772 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs559828004 |
chr8:19625775-19625776 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs145167339 |
chr8:19625835-19625836 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs530314649 |
chr8:19625839-19625840 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs530758879 |
chr8:19625877-19625878 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs182188341 |
chr8:19625896-19625897 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs7836144 |
chr8:19625912-19625913 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
33 |
rs540793855 |
chr8:19625941-19625942 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs554315920 |
chr8:19625947-19625948 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs186971744 |
chr8:19625968-19625969 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs113660860 |
chr8:19625990-19625991 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs10629321 |
chr8:19626017-19626018 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs34432826 |
chr8:19626018-19626019 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs118019468 |
chr8:19626024-19626025 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs72182468 |
chr8:19626027-19626028 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs202187301 |
chr8:19626036-19626037 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs398047124 |
chr8:19626037-19626038 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs60669912 |
chr8:19626038-19626039 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs139035591 |
chr8:19626061-19626062 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs7837390 |
chr8:19626120-19626121 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
46 |
rs191748603 |
chr8:19626223-19626224 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs184924732 |
chr8:19626263-19626264 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs564812780 |
chr8:19626280-19626281 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs527500633 |
chr8:19626342-19626343 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs547151225 |
chr8:19626350-19626351 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|